The incidence and multiplicity of HCC development in DEN-treated IDO-WT mice were 31% and 0.85 ± 1.46, respectively, whereas no HCC developed in the DEN-treated IDO-KO mice (P < 0.05). Here, IDO1 is linked to hepatocellular carcinoma.